APPEAL WATCH: If You Can’t Patent the Drug, Patent the Dosage
The Supreme Court of Canada (“SCC”) is set to review the patentability of dosage regimens for medical treatments. Last month, the SCC granted leave to appeal [41209] the Federal Court...
Tagged: Intellectual Property
Nova Chemicals Corporation v The Dow Chemical Co: The law of patent remedies takes a step forward
Introduction In Nova Chemicals Corporation v The Dow Chemical Company et al., 2022 SCC 43 (“Nova Chemicals”) the Supreme Court of Canada (“SCC”) clarified the test for determining a proper...
Double Royalties or Users’ Rights? The SCC Interprets the Copyright Act in SOCAN
In Society of Composers, Authors and Music Publishers of Canada v Entertainment Software Association, 2022 SCC 30 [SOCAN], the Supreme Court of Canada (“SCC”) heard an appeal from the Federal...
Awaiting the Next Chapter in Canadian Copyright Law: Leave Granted to SCC for York University, et al. v Canadian Copyright Licensing Agency (Access Copyright)
A leave to appeal has been granted for Access Copyright by the Supreme Court of Canada in York University, et al. v Canadian Copyright Licensing Agency SCC 76224 (“Access Copyright”)...
